0001062993-24-002320.txt : 20240207
0001062993-24-002320.hdr.sgml : 20240207
20240207172131
ACCESSION NUMBER: 0001062993-24-002320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farid Adrienne
CENTRAL INDEX KEY: 0001867310
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40498
FILM NUMBER: 24605874
MAIL ADDRESS:
STREET 1: C/O CENTURY THERAPEUTICS, INC.
STREET 2: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Century Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850119
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 842040295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 215-981-4000
MAIL ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-05
0001850119
Century Therapeutics, Inc.
IPSC
0001867310
Farid Adrienne
C/O CENTURY THERAPEUTICS, INC.
25 N 38TH STREET, 11TH FLOOR
PHILADELPHIA
PA
19104
0
1
0
0
Chief Operations Officer
0
Common Stock
2024-02-05
4
S
0
2035
3.841
D
115933
D
Common Stock
2024-02-06
4
S
0
1784
4.487
D
114149
D
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
/s/ Adrienne Farid
2024-02-07